PMS62 CERTOLIZUMAB PEGOL MONOTHERAPY PROVIDES SUSTAINED IMPROVEMENTS IN HOUSEHOLD PRODUCTIVITY AND DAILY ACTIVITIES IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS OVER 2 YEARS
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72215-X
https://www.valueinhealthjournal.com/article/S1098-3015(11)72215-X/fulltext
Title :
PMS62 CERTOLIZUMAB PEGOL MONOTHERAPY PROVIDES SUSTAINED IMPROVEMENTS IN HOUSEHOLD PRODUCTIVITY AND DAILY ACTIVITIES IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS OVER 2 YEARS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72215-X&doi=10.1016/S1098-3015(11)72215-X
First page :
A314
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
374